160 related articles for article (PubMed ID: 2855108)
1. The proliferation rate of intracranial tumors as defined by the monoclonal antibody KI 67. Application of the method to paraffin embedded specimens.
Böker DK; Stark HJ
Neurosurg Rev; 1988; 11(3-4):267-72. PubMed ID: 2855108
[TBL] [Abstract][Full Text] [Related]
2. Determination of the proliferative potential of human brain tumors using the monoclonal antibody Ki-67.
Deckert M; Reifenberger G; Wechsler W
J Cancer Res Clin Oncol; 1989; 115(2):179-88. PubMed ID: 2715168
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of proliferating cell nuclear antigen (PCNA) in intracranial glioma and meningioma.
Shih YH; Kadota Y; Sato K; Sueyoshi N; Shirai T
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Apr; 53(4):193-7. PubMed ID: 7911730
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of dUTPase in intracranial tumors.
Romeike BF; Böckeler A; Kremmer E; Sommer P; Krick C; Grässer F
Pathol Res Pract; 2005; 201(11):727-32. PubMed ID: 16325515
[TBL] [Abstract][Full Text] [Related]
5. Ki-67 immunoreactivity in human central nervous system tumors: a study with MIB 1 monoclonal antibody on archival material.
Karamitopoulou E; Perentes E; Diamantis I; Maraziotis T
Acta Neuropathol; 1994; 87(1):47-54. PubMed ID: 7511316
[TBL] [Abstract][Full Text] [Related]
6. Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value.
Heesters MA; Koudstaal J; Go KG; Molenaar WM
J Neurooncol; 1999; 44(3):255-66. PubMed ID: 10720205
[TBL] [Abstract][Full Text] [Related]
7. The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology.
Burger PC; Shibata T; Kleihues P
Am J Surg Pathol; 1986 Sep; 10(9):611-7. PubMed ID: 2428262
[TBL] [Abstract][Full Text] [Related]
8. Tenascin distribution in human brain tumours.
Castellani P; Dorcaratto A; Siri A; Zardi L; Viale GL
Acta Neurochir (Wien); 1995; 136(1-2):44-50. PubMed ID: 8748826
[TBL] [Abstract][Full Text] [Related]
9. Characterization of human gliomas by a monoclonal antibody both on tissue culture and paraffin-embedded sections.
Sipos L; Wakabayashi T; Szeifert GT; Fazekas I; Afra D
Neurol Res; 1992 Jun; 14(3):263-6. PubMed ID: 1355282
[TBL] [Abstract][Full Text] [Related]
10. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas.
Onda K; Davis RL; Shibuya M; Wilson CB; Hoshino T
Cancer; 1994 Oct; 74(7):1921-6. PubMed ID: 7521787
[TBL] [Abstract][Full Text] [Related]
11. Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumors.
Patsouris E; Stocker U; Kallmeyer V; Keiditsch E; Mehraein P; Stavrou D
Anticancer Res; 1988; 8(4):537-44. PubMed ID: 3052245
[TBL] [Abstract][Full Text] [Related]
12. PCNA and Ki-67 in central nervous system tumors: correlation with the histological type and grade.
Kayaselçuk F; Zorludemir S; Gümürdühü D; Zeren H; Erman T
J Neurooncol; 2002 Apr; 57(2):115-21. PubMed ID: 12125971
[TBL] [Abstract][Full Text] [Related]
13. Flow-cytometric DNA analysis and immunohistochemical measurement of Ki-67 and BUdR labeling indices in human brain tumors.
Nishizaki T; Orita T; Furutani Y; Ikeyama Y; Aoki H; Sasaki K
J Neurosurg; 1989 Mar; 70(3):379-84. PubMed ID: 2536805
[TBL] [Abstract][Full Text] [Related]
14. Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas.
Geiger KD; Stoldt P; Schlote W; Derouiche A
Am J Pathol; 2000 Dec; 157(6):1785-93. PubMed ID: 11106550
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical studies on human brain tumors using anti-Leu 7 monoclonal antibody in paraffin-embedded specimens.
Motoi M; Yoshino T; Hayashi K; Nose S; Horie Y; Ogawa K
Acta Neuropathol; 1985; 66(1):75-7. PubMed ID: 3887834
[TBL] [Abstract][Full Text] [Related]
16. Microvessel density in brain tumors.
Assimakopoulou M; Sotiropoulou-Bonikou G; Maraziotis T; Papadakis N; Varakis I
Anticancer Res; 1997; 17(6D):4747-53. PubMed ID: 9494601
[TBL] [Abstract][Full Text] [Related]
17. Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67.
Zuber P; Hamou MF; de Tribolet N
Neurosurgery; 1988 Feb; 22(2):364-8. PubMed ID: 2832782
[TBL] [Abstract][Full Text] [Related]
18. Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens.
Khoshyomn S; Maier H; Morimura T; Kitz K; Budka H
Acta Neuropathol; 1993; 86(6):582-9. PubMed ID: 7906072
[TBL] [Abstract][Full Text] [Related]
19. Identification of gliomas by morphological and immunocytochemical analysis in cell cultures.
Fazekas I; Kerekes E; Hegedús B; Nyáry I
Ideggyogy Sz; 2002 May; 55(5-6):173-9. PubMed ID: 12122877
[TBL] [Abstract][Full Text] [Related]
20. [Cell kinetics of oligodendroglioma and oligo-astrocytoma--Ki-67 PaP study].
Shibata T; Burger PC; Kleihues P
No To Shinkei; 1988 Aug; 40(8):779-85. PubMed ID: 3052541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
